APPLICATION
ANDA207568
TYPE
ANDA
ORIGINAL APPROVAL
2018-07-06
LATEST ACTION
2025-02-28
ROUTE
INTRAMUSCULAR, SUBCUTANEOUS, INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
EPINEPHRINEDiscontinued
EPINEPHRINE EQ 1MG BASE/ML (EQ 1MG BASE/ML) · SOLUTION · INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Approval history
2025-02-28Labeling · Supplement 4 · standardAP
2022-07-14Manufacturing (CMC) · Supplement 2 · unknownAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.